FOR INVESTORS
The deck looks right. Does the organisation hold up?
Your team can run the numbers. AI tools will make it faster. Soon, every firm will have the same analytical firepower.
What won't scale with AI is knowing what the numbers miss — the patterns that only surface after you've built companies yourself, led teams through scaling, watched supply chains buckle under real growth, and sat in boardrooms where the plan fell apart.
Thirty years as operator, leader, advisor, and investor in life sciences and deep tech. That's not a checklist. It's the layer that turns data into judgment.
Independent from the deal. Independent from execution. The read your in-house team can't give you — because they're part of the deal.
1.
SCALE-READINESS ASSESSMENT
Before you commit capital — a decision-grade read on whether scale will hold.
We examine go-to-market, operations, regulatory exposure, team depth, and cash resilience. We surface what will break at scale — not from a model, but from having been there.
→ A clear investment view: what's true, what's assumption, and what must change before the round makes sense.
When you're lead investor, the quality of your diligence is the quality of your reputation.
2.
DEAL FLOW SCREEN
More interesting companies than you have partner hours to evaluate.
We triage fast — separating deals where scale potential is real from ones to drop, and identifying what evidence must exist before you increase conviction. AI-accelerated triage, guided by pattern recognition no model has.
→ A short list where scale potential is real, and the specific proof points to move each one forward. Weeks of work compressed into days.
3.
BOARD SPARRING
The next step is irreversible. Get the decision right.
We support board-level decisions in investor language: constraints, trade-offs, conditions. What to fund next, which milestones matter, and the triggers to proceed, pause, or re-scope.
Board questions are about conviction, timing, and trust — we bring the independence to say what others in the room cannot.
→ Cleaner terms, fewer surprises, and a position you can defend to your co-investors and LPs.
